Historical record - last NADAC effective date: 6/19/2024
Product Information
M-END DMX LIQUID is a generic product labeled by R. A. McNeil Company, priced at $0.0723 per ML under NDC 12830081616. Its NADAC has been published 451 times since Feb 19, 2014.
M-END DMX LIQUID
Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide, Pseudoephedrine HydrochlorideStrength
.667; 10; 20 mg/5mL; mg/5mL; mg/5mL
Manufacturer
R. A. McNeil CompanyNDC
12830081616
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
DEXBROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
10/13/2011
Pharmacological Classes
Price Statistics
The NADAC for M-END DMX LIQUID has been published 451 times since Feb 19, 2014, and over the history we have for it it has risen 14.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0723 per ML |
|---|---|
| All-time high | $0.0723 (Jun 11, 2025) |
| All-time low | $0.0608 (Mar 22, 2017) |
| Median price | $0.0657 |
| Average price | $0.0667 |
| Largest weekly change | +11.1% (Apr 17, 2024) |
| Weeks tracked | 451 |
| Tracking since | Feb 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+11.4%
5Y
+11.4%
All
+14.7%
Last surveyed Jun 11, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
R. A. McNeil Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of M-END DMX LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for M-END DMX LIQUID, manufactured by R. A. McNeil Company, is $0.0723 per ML (NDC 12830081616), effective Jun 11, 2025.
How has the price of M-END DMX LIQUID changed over time?
Over the history we have for it, the NADAC for M-END DMX LIQUID has risen 14.7%. It has been tracked across 451 weekly CMS publications since Feb 19, 2014.
What are the highest and lowest recorded NADAC prices for M-END DMX LIQUID?
Since Feb 19, 2014, the NADAC for M-END DMX LIQUID has ranged from a low of $0.0608 (Mar 22, 2017) to a high of $0.0723 (Jun 11, 2025), with a median of $0.0657 per ML.
Are there cheaper alternatives to M-END DMX LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of M-END DMX LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures M-END DMX LIQUID?
M-END DMX LIQUID (NDC 12830081616) is labeled by R. A. McNeil Company, and CMS classifies it as a generic product.